Unpacking Averages: Creating an Industry-Specific Index to Track the FDA Regulatory Environment | Epstein Becker & Green
The regulatory environment at the US Food and Drug Administration (“FDA”) has a tremendous impact on how companies operate, and consequently data on that environment can be quite useful in business planning. In keeping with the theme of these posts of unpacking averages, it’s important to drill down sufficiently toContinue Reading